Nath Bio-Genes (India) Limited has informed the Exchange about Intimation of Conference Call

Board & Shareholder Meetings View source PDF

NATHBIOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.1%1-day move

₹180.60

prior close

₹199.01

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.5-0.0+1.7-0.4+4.1-4.4-1.5-3.6-4.7-10.2-3.7-2.3-9.2—

Up moveDown movePending

AI summary

Nath Bio-Genes (India) Limited has announced an earnings conference call scheduled for Tuesday, 5th May 2026 at 4:00 PM IST. The call will discuss Q4 and FY26 financial results. Key company participants include Managing Director Mr. Satish Kagliwal, CFO Mr. Amol Gupta, along with Sales Lead Mr. Harish Pandey and Research Lead Mr. Venkatesh Kulkarni. The call is being hosted by Go India Advisors and will be accessible via dial-in numbers provided. This is a routine quarterly earnings disclosure as required under listing regulations.

Likely market impact

This is a standard informational filing announcing the earnings call schedule. It indicates the company is communicating proactively with shareholders but does not contain any material financial updates or significant developments that would directly impact the stock price.